Transform Your Portfolio With This Simple Morning Trade!

Hi, I’m trading expert Dave Aquino and I want to show you how to take advantage of a trading opportunity happening nearly every morning at 9:30 EST.

My free guide, “How To Master The Retirement Trade” will show you exactly why traders in the know want to keep this trade a secret.

FRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.32%

Insider Buying (Last 12 Months): C$0.00

Insider Selling (Last 12 Months): C$33,213.50

Fennec Pharmaceuticals Insider Trading History Chart

Fennec Pharmaceuticals Share Price & Price History

C^$10.12

▲ +0.43 (4.44%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

How He Maintained A Staggering 97% Trading Win Rate Over 6+ Years

From Investing Daily | Ad

Economic Downturns, Pandemics, Wars—Nothing Shakes His Portfolio. He's Had Unearthly Wins In Both Bull And Bear Markets.

For Close To A Decade, He’s Maintained A Staggering 97% Trading Win Rate. He Didn't Follow The Wall Street Playbook, And Still Became A Millionaire Trader By The Age Of 37!

Watch His Exclusive Tell-All Interview Here Now

Fennec Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/28/2023	Chris Anigeron Rallis	Director	Sell	916	C$8.34	C$7,639.44
11/17/2022	Chris Anigeron Rallis	Director	Sell	333	C$10.63	C$3,538.69	30,018
10/20/2022	Chris Anigeron Rallis	Director	Sell	2,068	C$10.66	C$22,035.37	25,589
9/21/2022	Robert Christopher Andrade	Senior Officer	Sell	19,052	C$11.02	C$209,888.26	176,721
9/12/2022	Rostislav Christov Raykov	Director	Sell	16,666	C$0.93	C$15,479.38	21,081,996
7/18/2022	Chris Anigeron Rallis	Director	Buy	11,111	C$0.59	C$6,499.94	32,036

Free Stock Analysis Report: See The True Value of Any Stock

From Vector Vest | Ad

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

SEC Filings (Institutional Ownership Changes) for Fennec Pharmaceuticals (TSE:FRX)

50.66% of Fennec Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Today's Range

Now: C$10.12

C$9.94

C$10.12

50 Day Range

MA: C$10.70

C$9.59

C$11.27

52 Week Range

Now: C$10.12

C$9.59

C$14.41

Volume

300 shs

Average Volume

678 shs

Market Capitalization

C$268.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.25

Who are the company insiders with the largest holdings of Fennec Pharmaceuticals?: Fennec Pharmaceuticals' top insider shareholders include:
Rostislav Christov Raykov (Director)
Robert Christopher Andrade (Senior Officer)
Chris Anigeron Rallis (Director)
Learn More about top insider investors at Fennec Pharmaceuticals.